Polycystic ovary syndrome, economic burden, healthcare cost, diabetes mellitus, cardiovascular disease, dyslipidemia, metabolic syndrome, endometrial cancer The polycystic ovary syndrome (PCOS) results in a number of immediate and long-term morbidities that are associated with a significant impact on quality of life and on economic costs. Immediate morbidities include menstrual dysfunction and abnormal uterine bleeding, subfertility and infertility, and androgen excess-related dermatologic abnormalities including hirsutism, acne, and androgenic alopecia, and an increased risk of obstetrical complications such as pregnancy-induced hypertension and gestational diabetes. However, PCOS is also associated with an increased risk of various other long-term complications or morbidities including cancer, type 2 diabetes mellitus (DM), the metabolic syndrome (MS), and possibly cardiovascular disease (CVD).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Azziz, R. (2007). Long-Term Morbidity of PCOS. In: Azziz, R. (eds) The Polycystic Ovary Syndrome: Current Concepts On Pathogenesis And Clinical Care. Endocrine Updates, vol 27. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-69248-7_8
Download citation
DOI: https://doi.org/10.1007/978-0-387-69248-7_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-69246-3
Online ISBN: 978-0-387-69248-7
eBook Packages: MedicineMedicine (R0)